Fertility-sparing surgery after neo-adjuvant chemotherapy in women with cervical cancer larger than 4 cm: a systematic review.

David Viveros-Carreño Juliana Lucía Rodríguez-Castillo Gabriel Jaime Rendón PereiraJiri SlamaMichael J HalaskaHelena RobovaLina Caicedo

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)

Evidence for fertility-sparing surgery after neo-adjuvant chemotherapy in patients with cervical cancer and tumors >4 cm is limited, and this approach should be considered as an experimental intervention. As the use of non-radical surgery could be a risk factor, if neo-adjuvant chemotherapy is used, patients should undergo fertility-sparing radical surgery.

Keyphrases

minimally invasive
coronary artery bypass
robot assisted
surgical site infection
randomized controlled trial
end stage renal disease
risk factors
ejection fraction
chronic kidney disease
percutaneous coronary intervention
childhood cancer